This inventor holds 1 USPTO granted patent. Top assignee: Uniroyal Chemical Company, Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: John W. Harris: Innovator in Antiretroviral Compounds
Introduction
John W. Harris is a notable inventor based in Sugar Land, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiretroviral compounds. His work focuses on combating retrovirus infections, which are critical in the fight against diseases such as HIV.
Latest Patents
Harris holds a patent for "Antiretroviral compounds and compositions." This patent includes certain pyridine and quinoline derivatives that inhibit the replication of retroviruses, specifically HIV-1, HIV-2, and human cytomegalovirus (HCMV). The pharmaceutical compositions described in his patent are useful in methods of treating or inhibiting these retrovirus infections. He has 1 patent to his name.
Career Highlights
Harris is associated with Uniroyal Chemical Company, Inc., where he has contributed to various innovative projects. His expertise in chemistry and pharmaceuticals has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Harris has worked alongside notable colleagues, including Arthur D. Brewer and Stephen E. Cantor. These collaborations have further enhanced his research and development efforts in the field of antiretroviral therapies.
Conclusion
John W. Harris is a distinguished inventor whose work in antiretroviral compounds has made a significant impact on the pharmaceutical industry. His contributions continue to play a vital role in the ongoing battle against retroviral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile